Rectal & Anal Tissue Support

Clinical Overview

This service provides healthcare providers with options for customized medication strengths and combinations that are not available in standard over-the-counter or commercial rectal preparations.

Formulation Logic: Pharmacists can combine diverse classes of pharmaceutical actives—such as vasodilators (e.g., Nifedipine or Diltiazem), localized anesthetics (Lidocaine), and corticosteroids (Hydrocortisone)—into a single, uniform vehicle.
Targeted Delivery: Formulations are designed to act locally on the affected tissue, which may reduce the potential for systemic side effects often associated with oral medications.
Base Technology: Preparations are often compounded in specialized bases like VersaPro™ Anhydrous or specialized muco-adhesive gels that are engineered to remain in contact with the mucosal lining for an extended period.

Commonly used Compounding Solutions

Customized Nifedipine Rectal Ointment (Available with Lidocaine)

This solution is compounded to provide unique concentrations of Nifedipine (0.2%, 0.3%, or 0.5%) as specified by a healthcare provider’s prescription.

The medication is incorporated into a specialized Lanolin/Petrolatum vehicle that is engineered to act as a protective moisture barrier while maintaining the medication in direct contact with the targeted tissue.
For patients requiring additional localized support, Lidocaine (5%) can be integrated into the ointment to offer a comprehensive, practitioner-customized preparation.
This delivery system is specifically chosen to facilitate localized absorption through the mucosal lining while minimizing the systemic distribution often seen with oral calcium channel blockers.

Technical Specifications →

Customized Diltiazem Rectal Ointment (Available with Lidocaine)

This preparation is a practitioner-directed formulation designed for localized application to the rectal mucosa.

It utilizes Diltiazem (1% – 2%), a calcium channel blocker, which is prepared in an anhydrous petrolatum base to ensure stability and a smooth, consistent texture for ease of application.
The formulation may be compounded with Lidocaine (5%), a localized anesthetic, to provide a multi-modal approach within a single application.
By applying the medication topically to the affected area, the active ingredients work locally on the tissue, providing a targeted alternative to systemic oral medications that may have broader metabolic effects.

Technical Specifications →

Related Symptoms

• Requirement for custom medication strength
• Sensitivity
• Preference for localized rather than systemic therapy

Your cart is empty

Rectal & Anal Tissue Support

Clinical Overview

Mixwell Compounding Pharmacy